More importantly, while the knockdown of cJUN abrogated the expression of XRCC4 (Figure 6b), JNK loss also completely abolished the expression of XRCC4 in cisplatin-resistant ovarian cancer cell lines (Figure 6c). Here, XRCC4 is linked to ovarian carcinoma.